StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.45+0.30 (+13.95%)

Close on Nov 17, 2026Market cap $106.07MP/E –Yield –

NRX Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

NRX Pharmaceuticals's enterprise value was $78.62M on Nov 11, 2026, against $60.64M a year earlier. Over the last 5 years it ranged from -$2.92M to $478.97M, with a median of $44.17M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$78.62M+15.9%
2025Dec 31, 2025$67.84M+190.2%
2024Dec 31, 2024$23.38M-41.2%
2023Dec 29, 2023$39.77M-30.0%
2022Dec 30, 2022$56.83M-88.1%
2021Oct 29, 2021$478.97M-40.3%
2020Dec 31, 2020$802.23M+120.0%
2019Dec 31, 2019$364.72M+10.7%
2018Dec 31, 2018$329.55M–

More NRX Pharmaceuticals figures

See a number that looks wrong?